Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 45

References for PMC Articles for PubMed (Select 22118459)

1.

Ligand-induced modulation of the free-energy landscape of G protein-coupled receptors explored by adaptive biasing techniques.

Provasi D, Artacho MC, Negri A, Mobarec JC, Filizola M.

PLoS Comput Biol. 2011 Oct;7(10):e1002193. doi: 10.1371/journal.pcbi.1002193. Epub 2011 Oct 13.

2.

CODA-RET reveals functional selectivity as a result of GPCR heteromerization.

Urizar E, Yano H, Kolster R, Galés C, Lambert N, Javitch JA.

Nat Chem Biol. 2011 Jul 24;7(9):624-30. doi: 10.1038/nchembio.623.

3.

A multicenter, inpatient, phase 2, double-blind, placebo-controlled dose-ranging study of LY2140023 monohydrate in patients with DSM-IV schizophrenia.

Kinon BJ, Zhang L, Millen BA, Osuntokun OO, Williams JE, Kollack-Walker S, Jackson K, Kryzhanovskaya L, Jarkova N; HBBI Study Group.

J Clin Psychopharmacol. 2011 Jun;31(3):349-55. doi: 10.1097/JCP.0b013e318218dcd5.

PMID:
21508856
4.

Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists.

Moreno JL, Holloway T, Albizu L, Sealfon SC, González-Maeso J.

Neurosci Lett. 2011 Apr 15;493(3):76-9. doi: 10.1016/j.neulet.2011.01.046. Epub 2011 Jan 27.

5.

Disrupting 5-HT(2A) receptor/PDZ protein interactions reduces hyperalgesia and enhances SSRI efficacy in neuropathic pain.

Pichon X, Wattiez AS, Becamel C, Ehrlich I, Bockaert J, Eschalier A, Marin P, Courteix C.

Mol Ther. 2010 Aug;18(8):1462-70. doi: 10.1038/mt.2010.101. Epub 2010 Jun 8.

6.

Group II metabotropic glutamate receptors and schizophrenia.

Moreno JL, Sealfon SC, González-Maeso J.

Cell Mol Life Sci. 2009 Dec;66(23):3777-85. doi: 10.1007/s00018-009-0130-3. Epub 2009 Aug 26. Review.

7.

Combined administration of an mGlu2/3 receptor agonist and a 5-HT 2A receptor antagonist markedly attenuate the psychomotor-activating and neurochemical effects of psychostimulants.

Uslaner JM, Smith SM, Huszar SL, Pachmerhiwala R, Hinchliffe RM, Vardigan JD, Hutson PH.

Psychopharmacology (Berl). 2009 Nov;206(4):641-51. doi: 10.1007/s00213-009-1644-y. Epub 2009 Aug 26.

PMID:
19707745
8.

Allosteric communication between protomers of dopamine class A GPCR dimers modulates activation.

Han Y, Moreira IS, Urizar E, Weinstein H, Javitch JA.

Nat Chem Biol. 2009 Sep;5(9):688-95. doi: 10.1038/nchembio.199. Epub 2009 Aug 2.

9.

Crosstalk between GABAB and mGlu1a receptors reveals new insight into GPCR signal integration.

Rives ML, Vol C, Fukazawa Y, Tinel N, Trinquet E, Ayoub MA, Shigemoto R, Pin JP, Prézeau L.

EMBO J. 2009 Aug 5;28(15):2195-208. doi: 10.1038/emboj.2009.177. Epub 2009 Jul 9.

10.

CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields.

Vanommeslaeghe K, Hatcher E, Acharya C, Kundu S, Zhong S, Shim J, Darian E, Guvench O, Lopes P, Vorobyov I, Mackerell AD Jr.

J Comput Chem. 2010 Mar;31(4):671-90. doi: 10.1002/jcc.21367.

11.

The structure and function of G-protein-coupled receptors.

Rosenbaum DM, Rasmussen SG, Kobilka BK.

Nature. 2009 May 21;459(7245):356-63. doi: 10.1038/nature08144. Review.

12.

G protein-coupled receptor hetero-dimerization: contribution to pharmacology and function.

Milligan G.

Br J Pharmacol. 2009 Sep;158(1):5-14. doi: 10.1111/j.1476-5381.2009.00169.x. Epub 2009 Mar 20. Review.

13.

Psychedelics and schizophrenia.

González-Maeso J, Sealfon SC.

Trends Neurosci. 2009 Apr;32(4):225-32. doi: 10.1016/j.tins.2008.12.005. Epub 2009 Mar 5. Review.

PMID:
19269047
14.

The 'atypicality' of antipsychotics: a concept re-examined and re-defined.

Gründer G, Hippius H, Carlsson A.

Nat Rev Drug Discov. 2009 Mar;8(3):197-202. doi: 10.1038/nrd2806. Epub 2009 Feb 13. Review.

PMID:
19214197
15.

Current status of inverse agonism at serotonin2A (5-HT2A) and 5-HT2C receptors.

Aloyo VJ, Berg KA, Spampinato U, Clarke WP, Harvey JA.

Pharmacol Ther. 2009 Feb;121(2):160-73. doi: 10.1016/j.pharmthera.2008.10.010. Epub 2008 Dec 6. Review.

PMID:
19109993
16.

In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems.

Meltzer HY, Huang M.

Prog Brain Res. 2008;172:177-97. doi: 10.1016/S0079-6123(08)00909-6. Review.

PMID:
18772033
17.

Detection of heteromerization of more than two proteins by sequential BRET-FRET.

Carriba P, Navarro G, Ciruela F, Ferré S, Casadó V, Agnati L, Cortés A, Mallol J, Fuxe K, Canela EI, Lluís C, Franco R.

Nat Methods. 2008 Aug;5(8):727-33. doi: 10.1038/nmeth.1229. Epub 2008 Jun 29.

PMID:
18587404
18.

Identification of a serotonin/glutamate receptor complex implicated in psychosis.

González-Maeso J, Ang RL, Yuen T, Chan P, Weisstaub NV, López-Giménez JF, Zhou M, Okawa Y, Callado LF, Milligan G, Gingrich JA, Filizola M, Meana JJ, Sealfon SC.

Nature. 2008 Mar 6;452(7183):93-7. doi: 10.1038/nature06612. Epub 2008 Feb 24.

19.

Well-tempered metadynamics: a smoothly converging and tunable free-energy method.

Barducci A, Bussi G, Parrinello M.

Phys Rev Lett. 2008 Jan 18;100(2):020603. Epub 2008 Jan 18.

PMID:
18232845
20.

Conformational cross-talk between alpha2A-adrenergic and mu-opioid receptors controls cell signaling.

Vilardaga JP, Nikolaev VO, Lorenz K, Ferrandon S, Zhuang Z, Lohse MJ.

Nat Chem Biol. 2008 Feb;4(2):126-31. doi: 10.1038/nchembio.64. Epub 2008 Jan 13.

PMID:
18193048
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk